Clinical trials
Terminated Phase 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2006 | 1 |
| 2009 | 1 |
| 2012 | 2 |
| 2014 | 1 |
| 2017 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 1 |
| Baxalta now part of Shire | 1 |
| Children's Hospital of Philadelphia | 1 |
| Dana-Farber Cancer Institute | 1 |
| Hospital Israelita Albert Einstein | 1 |
| Kiadis Pharma | 1 |
| M.D. Anderson Cancer Center | 1 |
| Martin, Paul | 1 |
| OHSU Knight Cancer Institute | 1 |
| Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 13 |
| Leukemia | 7 |
| Leukemia, Myeloid, Acute | 5 |
| Burkitt Lymphoma | 4 |
| Graft vs Host Disease | 4 |
| Myelodysplastic Syndromes | 4 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Leukemia, Myeloid, Accelerated Phase | 3 |
| Leukemia, Myeloid, Chronic-Phase | 3 |
| Leukemia, Myelomonocytic, Chronic | 3 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.